Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Antonio Gutierrez

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Cardiovascular Medicine|February 26, 2018
Robotic-Assisted Percutaneous Coronary InterventionNathan Lo, Jorge Antonio Gutierrez, Rajesh V Swaminathan
Interventional Cardiology Clinics|March 6, 2025
Femoropopliteal Interventions for Peripheral Artery Disease: A Review of Current Evidence and Future DirectionsAdam P Johnson, Rajesh V Swaminathan, Samantha D Minc, et al.
Vascular Medicine (London, England)|October 5, 2021
No benefit of vorapaxar on walking performance in patients with intermittent claudicationShirling Tsai, Yulun Liu, Mohamad Amer Alaiti, et al.
European Heart Journal Open|April 3, 2025
Efficacy and safety of renal denervation therapy in hypertension: a meta-analysisHusam M Salah, Jorge Antonio Gutierrez, Jennifer A Rymer, et al.
JAMA Network Open|September 9, 2025
Daylight Savings Time and Acute Myocardial InfarctionJennifer A Rymer, Shuang Li, Karen Chiswell, et al.
The American Journal of Cardiology|October 28, 2018
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial)Jorge Antonio Gutierrez, Benjamin M Scirica, Marc P Bonaca, et al.
Heart Failure Reviews|March 9, 2026
Intensive blood pressure control in heart failure with preserved ejection fraction: a symptom-modifying strategyMuhammad Sameer Arshad, Muhammad Saad, Philipp Lurz, et al.
Atherosclerosis|November 6, 2021
Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trialMarc D Samsky, Robert J Mentz, Amanda Stebbins, et al.
Journal of the American Heart Association|February 8, 2021
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health AdministrationJorge Antonio Gutierrez, Sunil V Rao, William Schuyler Jones, et al.
Circulation. Cardiovascular Interventions|April 24, 2025
Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) StudyRajesh V Swaminathan, Guillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Cardiovascular Medicine|February 26, 2018
Robotic-Assisted Percutaneous Coronary InterventionNathan Lo, Jorge Antonio Gutierrez, Rajesh V Swaminathan
Interventional Cardiology Clinics|March 6, 2025
Femoropopliteal Interventions for Peripheral Artery Disease: A Review of Current Evidence and Future DirectionsAdam P Johnson, Rajesh V Swaminathan, Samantha D Minc, et al.
Vascular Medicine (London, England)|October 5, 2021
No benefit of vorapaxar on walking performance in patients with intermittent claudicationShirling Tsai, Yulun Liu, Mohamad Amer Alaiti, et al.
European Heart Journal Open|April 3, 2025
Efficacy and safety of renal denervation therapy in hypertension: a meta-analysisHusam M Salah, Jorge Antonio Gutierrez, Jennifer A Rymer, et al.
JAMA Network Open|September 9, 2025
Daylight Savings Time and Acute Myocardial InfarctionJennifer A Rymer, Shuang Li, Karen Chiswell, et al.
The American Journal of Cardiology|October 28, 2018
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial)Jorge Antonio Gutierrez, Benjamin M Scirica, Marc P Bonaca, et al.
Heart Failure Reviews|March 9, 2026
Intensive blood pressure control in heart failure with preserved ejection fraction: a symptom-modifying strategyMuhammad Sameer Arshad, Muhammad Saad, Philipp Lurz, et al.
Atherosclerosis|November 6, 2021
Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trialMarc D Samsky, Robert J Mentz, Amanda Stebbins, et al.
Journal of the American Heart Association|February 8, 2021
Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health AdministrationJorge Antonio Gutierrez, Sunil V Rao, William Schuyler Jones, et al.
Circulation. Cardiovascular Interventions|April 24, 2025
Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) StudyRajesh V Swaminathan, Guillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, et al.
Pageof 1